New biomarker could aid in early diagnosis of Alzheimer’s disease

Research scientist using digital tablet to browse internet and find biochemistry discovery. Female chemist working with device to create pharmaceutical cure, microbiology experiment.

A definitive diagnosis of Alzheimer’s disease (AD) was once only possible after someone had died, but recent biomarker studies have led to the development of imaging and spinal fluid tests for those still living.

Failing IT infrastructure is undermining safe health care in the National Health Service

Previous article

AI-powered system can predict healing of venous leg ulcers

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News